title: The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.
abstract: The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces apoptosis after cell cycle arrest at the G2 phase in primate cells. We have reported previously that C81, a carboxy-terminally truncated form of Vpr, interferes with cell proliferation and results in apoptosis without G2 arrest. Here, we investigated whether this property of Vpr and C81 could be exploited for use as a potential anticancer agent. First, we demonstrated that C81 induced G1 arrest and apoptosis in all tumor cells tested. In contrast, Vpr resulted in G2 arrest and apoptosis in HeLa and 293 T cells. Vpr also suppressed the damaged-DNA-specific binding protein 1 (DDB1) in HepG2 cells, thereby inducing apoptosis without G2 arrest. G2 arrest was restored when DDB1 was overexpressed in cells that also expressed Vpr. Surprisingly, C81 induced G2 arrest when DDB1 was overexpressed in HepG2 cells, but not in HeLa or 293 T cells. Thus, the induction of Vpr- and C81-mediated cell cycle arrest appears to depend on the cell type, whereas apoptosis was observed in all tumor cells tested. Overall, Vpr and C81 have potential as novel therapeutic agents for treatment of cancer.
authors.affiliation: Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. mizuho-624.1128@s7.dion.ne.jp
authors.forename: Mizuho
authors.initials: M
authors.lastname: Nonaka
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: Shin-Nosuke
authors.initials: SN
authors.lastname: Takeshima
authors.forename: Yoko
authors.initials: Y
authors.lastname: Aida
references.citation: Mol Cell. 2006 Sep 1;23(5):709-21
references.pmid: 16949367
references.citation: Oncogene. 2002 Jul 11;21(30):4613-25
references.pmid: 12096338
references.citation: Ann N Y Acad Sci. 1960 Oct 5;89:474-83
references.pmid: 13706673
references.citation: Nat Med. 1998 Jan;4(1):65-71
references.pmid: 9427608
references.citation: Microbes Infect. 2006 Mar;8(3):670-9
references.pmid: 16480911
references.citation: Nature. 2006 Oct 5;443(7111):590-3
references.pmid: 16964240
references.citation: Curr HIV Res. 2009 Mar;7(2):163-8
references.pmid: 19275585
references.citation: Mol Ther. 2006 Nov;14(5):647-55
references.pmid: 16950655
references.citation: Curr Opin Cell Biol. 2004 Dec;16(6):629-33
references.pmid: 15530773
references.citation: J Mol Biol. 2003 Mar 14;327(1):215-27
references.pmid: 12614620
references.citation: Virology. 2000 Oct 10;276(1):16-26
references.pmid: 11021990
references.citation: Oncogene. 2008 Jan 3;27(1):32-43
references.pmid: 17653096
references.citation: Mol Cell Biol. 1987 Jan;7(1):379-87
references.pmid: 3031469
references.citation: J Virol. 2005 Mar;79(6):3557-64
references.pmid: 15731250
references.citation: J Virol. 2000 Jul;74(13):6058-67
references.pmid: 10846089
references.citation: Retrovirology. 2005 Feb 22;2:11
references.pmid: 15725353
references.citation: Biochem Biophys Res Commun. 1997 Mar 17;232(2):550-4
references.pmid: 9125220
references.citation: J Biol Chem. 1994 Jun 3;269(22):15577-82
references.pmid: 8195203
references.citation: J Biol Chem. 2007 Sep 14;282(37):27046-27057
references.pmid: 17620334
references.citation: Science. 1980 Jul 25;209(4455):497-9
references.pmid: 6248960
references.citation: Mol Cell Biol. 2004 Nov;24(21):9286-94
references.pmid: 15485898
references.citation: Nature. 1979 Dec 6;282(5739):615-6
references.pmid: 233137
references.citation: Virology. 1999 Oct 25;263(2):313-22
references.pmid: 10544105
references.citation: Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7311-5
references.pmid: 8041786
references.citation: Gene. 1996;173(1 Spec No):33-8
references.pmid: 8707053
references.citation: J Virol. 2008 Feb;82(3):1066-72
references.pmid: 17855541
references.citation: Nat Cell Biol. 2006 Nov;8(11):1277-83
references.pmid: 17041588
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11778-83
references.pmid: 17609381
references.citation: Curr HIV Res. 2009 Mar;7(2):136-43
references.pmid: 19275582
references.citation: Virol J. 2007 Jun 08;4:57
references.pmid: 17559673
references.citation: J Biol Chem. 2008 Aug 1;283(31):21686-92
references.pmid: 18524771
references.citation: Microbes Infect. 2007 Apr;9(4):490-7
references.pmid: 17347016
references.citation: Cancer Biol Ther. 2007 Aug;6(8):1269-75
references.pmid: 17700061
references.citation: Cell Cycle. 2007 Jan 15;6(2):182-8
references.pmid: 17314515
references.citation: Genes Dev. 2006 Nov 1;20(21):2949-54
references.pmid: 17079684
references.citation: J Virol. 2006 Nov;80(21):10407-18
references.pmid: 16956949
references.citation: Microbes Infect. 2005 Jul;7(9-10):1150-60
references.pmid: 15908254
references.citation: J Virol. 2002 Oct;76(19):9724-34
references.pmid: 12208951
references.citation: J Virol. 2007 May;81(10):5284-93
references.pmid: 17344301
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4130-5
references.pmid: 17360488
references.citation: J Virol. 1996 Apr;70(4):2516-24
references.pmid: 8642681
references.citation: J Virol. 1997 Jun;71(6):4331-8
references.pmid: 9151821
references.citation: Curr HIV Res. 2005 Jan;3(1):43-51
references.pmid: 15638722
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5281-6
references.pmid: 9560267
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12039-43
references.pmid: 10518572
references.citation: PLoS Pathog. 2007 Jul;3(7):e85
references.pmid: 17630831